Mueller Industries (MLI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
22 Oct, 2025Executive summary
Net sales for Q3 2025 increased 8.0% year-over-year to $1.08 billion, with net income up 23.4% to $208.1 million and diluted EPS rising to $1.88 from $1.48.
Growth was driven by higher selling prices, recent acquisitions (Nehring and Elkhart), and insurance gains.
Gross margin improved to 31.5% from 27.6% in Q3 2024, reflecting favorable pricing and operational efficiencies.
Operating income for Q3 2025 was $276.1 million, up from $206.7 million year-over-year.
Cash and cash equivalents at quarter-end were $1.3 billion, with no outstanding debt and a current ratio of 4.8 to 1.
Financial highlights
Net income for the nine months ended September 27, 2025, was $611.5 million, a 30.9% increase year-over-year.
Diluted EPS for the nine months was $5.48, up from $4.10 in the prior year period.
Dividends per share increased to $0.25 in Q3 2025 from $0.20 in Q3 2024.
Net cash from operations was $310.1 million for the quarter.
Year-to-date net sales reached $3.22 billion, up from $2.85 billion for the same period last year.
Outlook and guidance
Management expects the annual effective tax rate to remain consistent with the first nine months at 25%.
Management is optimistic, expecting to benefit from greater production efficiencies and tariffs, and plans to accelerate U.S. manufacturing and onshoring.
Cash flow from operations, available credit, and cash on hand are expected to be sufficient for liquidity needs.
The share repurchase program is extended through July 2026, with 21 million shares remaining authorized for repurchase.
Latest events from Mueller Industries
- Delivers strong growth, profitability, and returns through market leadership and disciplined strategy.MLI
Investor presentation16 Mar 2026 - Record net income and strong cash position set the stage for continued growth in 2026.MLI
Q4 20253 Feb 2026 - Record earnings, major acquisitions, and a 25% dividend hike highlight 2024's achievements.MLI
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditor approval, and executive compensation.MLI
Proxy Filing2 Dec 2025 - Strong sales and profit growth achieved, supported by acquisitions and insurance gains.MLI
Q2 202523 Jul 2025 - Sales and net income surged, fueled by acquisitions and higher copper prices.MLI
Q3 202413 Jun 2025 - Q2 sales up 11.2% YoY, net income down 9.9%, with Nehring boosting segment growth.MLI
Q2 202413 Jun 2025 - Sales and earnings rose on acquisitions and pricing, with strong cash and share buybacks.MLI
Q1 20256 Jun 2025 - Q4 2024 delivered record sales and income, with acquisitions fueling future growth.MLI
Q4 20245 Jun 2025